Slider-home

• 
  Second HIV-AIDS patient “cured”: Our members interviewed

  Listen to an interview with Dr. Nicole Bernard on the remission reported this week at the CROI conference by European researchers.
• 
  CIHR Project Grant (Fall 2018)

  Congratulations to the numerous CIHR Project Grant recipients!
• 
  Viral communications hacking boosts leishmania infections

  Read more on the findings
• 
  Can a smart app encourage HIV-self testing in Canada?

  Read more in a study from Dr. Nitika Pai's team. 
• 
  Dr. Jean-Pierre Routy research featured in Découverte

  Watch the video to see how viruses such as HIV hide from the immune system in testicles. 
• 
  Canadian women leaders in global health

  Dr. Amrita Daftari, Dr. Theresa Gyorkos and Dr. Nitika Pai named in the list. 
• 
  New study on EpiPen use

  Dr. Ben-Soshan's new study on EpiPen use was widely featured in the media.
• 
  IDIGH Travel Awards

  Congratulations to our awarded trainees !
• 
  New leadership for the McGill TB Centre

  Dr. Madhukar Pai has been appointed Director.
• 
  CIHR Foundation Grant

  Congratulations to Dr. Don Sheppard who obtained a CIHR Foundation Grant to fight fungal infections!
• 
  Dr. Michael Libman interviewed on CTV News

  Advice on preventing Lyme disease.
• 
  Dr. Giada Sebastiani interviews by JdeM and TVA

  Learn on non-alcoholic fatty liver disease !
  
• 
  A $15-Million Gift to Fight infections

  Congratulations to Dr. Don Sheppard and  Dr. Marcel Behr for receiving a a $15-Million donation from The Doggone Foundation
• 
  Québec Science’s top discoveries

  Don Sheppard and Brendan Snarr making Quebec science magazine’s top ten science discoveries list.

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by programme scientists.